Efficacy, safety and treatment satisfaction of transition to a regimen of insulin degludec/aspart: A pilot study

Table 3 Comparison of diabetes treatment satisfaction questionnaire, n (%)/mean ± SD¹

Question	Baseline	At 12 weeks	P value
Satisfaction with current treatment	4.0 ± 1.3	5.4 ± 0.9	0.01
The occurrence rate of unacceptable hyperglycemia	2.1 ± 1.7	0.8 ± 1.5	0.03
The occurrence rate of unacceptable hypoglycemia	1.5 ± 1.8	0.7 ± 1.3	0.11
Convenience	3.6 ± 1.5	5.4 ± 0.08	< 0.01
Flexibility	4.6 ± 1.3	5.0 ± 1.1	0.12
Understanding of diabetes	4.3 ± 1.0	5.0 ± 1.1	0.02
Recommend treatment to others	3.1 ± 1.8	5.0 ± 1.8	0.01
Willingness to continue	3.6 ± 1.6	5.3 ± 1.0	< 0.01
Overall treatment satisfaction	23.1 ± 5.4	31.0 ± 5.8	< 0.01

¹The aggregate score for treatment satisfaction is calculated by totaling the scores for item 1 and items 4 to 8 of the Diabetes Treatment Satisfaction Questionnaire.